Journal article icon

Journal article

Brain and muscle chemistry in myalgic encephalitis/chronic fatigue syndrome (ME/CFS) and long COVID: a 7T magnetic resonance spectroscopy study

Abstract:
Myalgic encephalitis/chronic fatigue syndrome (ME/CFS) is a common debilitating medical condition, whose main symptoms - fatigue, post-exertional malaise and cognitive dysfunction – are also present in many cases of long COVID. Magnetic resonance spectroscopy (MRS) allows the insight into their pathophysiology through exploration of a range of biochemicals putatively relevant to aetiological processes, in particular mitochondrial dysfunction and energy metabolism. 24 patients with ME/CFS, 25 patients with long COVID and 24 healthy controls (HC) underwent brain (pregenual and dorsal anterior cingulate cortex, respectively, pgACC and dACC) and calf muscle MRS scanning at 7 Tesla, followed by a computerised cognitive assessment. Compared to HC, ME/CFS patients had elevated levels of lactate in both pgACC and dACC, while long COVID patients had lowered levels of total choline in dACC. By contrast, skeletal muscle metabolites at rest did not significantly differ between the groups. The changes in lactate in ME/CFS are consistent with the presence of energetic stress and mitochondrial dysfunction. A reduction in total choline in long COVID is of interest in the context of the recently reported association between blood clots and ‘brain fog’, and earlier animal studies showing that choline might prevent intravascular coagulation. Importantly, differences in findings between ME/CFS and long COVID suggest that the underlying neurobiological mechanisms, while leading to similar clinical presentations, may differ. An important implication is that patients with ME/CFS and those with fatigue in the course of long COVID should not be studied as a single group, at least until the mechanisms are better understood.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/s41380-025-03108-8

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Sub department:
Psychiatry
Role:
Author
ORCID:
0000-0002-5973-3765
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Sub department:
Psychiatry
Role:
Author
ORCID:
0000-0001-6297-8432
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Sub department:
Psychiatry
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author


Publisher:
Springer Nature [academic journals on nature.com]
Journal:
Molecular Psychiatry More from this journal
Volume:
30
Issue:
11
Pages:
5215-5226
Publication date:
2025-07-12
Acceptance date:
2025-07-01
DOI:
EISSN:
1476-5578
ISSN:
1359-4184


Language:
English
Source identifiers:
3379623
Deposit date:
2025-10-16
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP